Pricing Log in Create free account

Calidi Biotherapeutics, Inc. (CLDI) vs HCW Biologics Inc. (HCWB)

Calidi Biotherapeutics, Inc. and HCW Biologics Inc. are both Biotechnology companies. Calidi Biotherapeutics, Inc. and HCW Biologics Inc. are of similar size ($2.5M and $2.3M). Calidi Biotherapeutics, Inc. has the higher net margin (0.00% vs −329.4%) and the higher return on invested capital (0.00% vs −36.2%). Across the 13 metrics below, Calidi Biotherapeutics, Inc. leads on 7 and HCW Biologics Inc. on 6.

Valuation

Metric CLDI HCWB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.20 9.40
P/B 0.32 0.18 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.08 n/m 0.66
EV/Sales n/m 1.12 9.02
Earnings yield (7,757.14%) (2,786.94%) (32.88%)
Free cash flow yield (1,800.34%) (915.31%) (23.13%)

Profitability

Metric CLDI HCWB Biotechnology median
Gross margin — 95.91% 68.51%
Operating margin 0.00% (114.02%) 0.00%
Net margin 0.00% (329.38%) 0.00%
Free cash flow margin 0.00% (180.57%) 0.00%
Return on equity (900.56%) (600.32%) (51.96%)
Return on assets (283.36%) (79.52%) (46.06%)
Return on invested capital 0.00% (36.15%) 0.00%

Growth

Metric CLDI HCWB Biotechnology median
Revenue growth (TTM) — 706.96% 6.76%
EPS growth (last fiscal year) 83.31% 65.49% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CLDI HCWB Biotechnology median
Debt to equity 0.24 0.88 0.00
Current ratio 1.68 0.06 4.97
Net debt to EBITDA 0.26 (0.40) 1.01

Dividend

Metric CLDI HCWB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLDI HCWB Biotechnology median
Market cap 2.49m 2.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack